Movatterモバイル変換

Jump to content

(RS)-etodolac(Q2465218)

From Wikidata

group of stereoisomers

AY-24236
1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
(+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
(1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid

Language	Label	Description	Also known as
default for all languages	No label defined
English	(RS)-etodolac	group of stereoisomers	AY-24236 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid (+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid (1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid

Statements

group of stereoisomers

0 references

chemical compound

0 references

0 references

chemical structure

Etodolac.png
493 × 392; 5 KB

structure representation with unlabelled terminal carbon atoms

0 references

Etodolac structure.svg
215 × 98; 25 KB

structure representation with labelled terminal carbon atoms

0 references

287.152dalton

1 reference

language of work or name

etodolac(English)

17 November 2016

chemical formula

C₁₇H₂₁NO₃

1 reference

language of work or name

etodolac(English)

17 November 2016

canonical SMILES

CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O

1 reference

language of work or name

etodolac(English)

17 November 2016

defined daily dose

0.4gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=M01AB08

active ingredient in

1 reference

14 February 2018

World Health Organisation international non-proprietary name

etodolac(English)

1 reference

language of work or name

etodolac(English)

3 October 2016

medical condition treated

1 reference

language of work or name

13 December 2016

1 reference

language of work or name

13 December 2016

rheumatoid arthritis

1 reference

language of work or name

13 December 2016

rheumatoid arthritis

25 November 1997

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/2M36281008

https://www.drugs.com/pro/etodolac.html

25 November 1997

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/2M36281008

https://www.drugs.com/pro/etodolac.html

significant drug interaction

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

gastrointestinal haemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

gastrointestinal haemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

gastrointestinal haemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

gastrointestinal haemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

gastrointestinal haemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

gastrointestinal haemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bone marrow failure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

gastrointestinal toxicity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

retroperitoneal hemorrhage

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

increased systemic arterial blood pressure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

peptic ulcer disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

peptic ulcer disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

peptic ulcer disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

peptic ulcer disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

peptic ulcer disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

peptic ulcer disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

acute kidney injury

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Prostaglandin-endoperoxide synthase 2

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Prostaglandin-endoperoxide synthase 2

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL622

legal status (medicine)

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.(English)

LiverTox likelihood score

LiverTox toxicity likelihood category C

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Etodolac

5 April 2018

subject has role

cyclooxygenase inhibitors

1 reference

5 March 2018

COX-2 inhibitor

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

non-steroidal anti-inflammatory drug

1 reference

27 February 2018

female reproductive toxicant

20 August 1999

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/etodolac

developmental toxicant

20 August 1999

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/etodolac

Commons category

Etodolac

0 references

Identifiers

InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)

1 reference

language of work or name

etodolac(English)

17 November 2016

NNYBQONXHNTVIJ-UHFFFAOYSA-N

2 references

language of work or name

etodolac(English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

etodolac(English)

17 November 2016

NNYBQONXHNTVIJ-UHFFFAOYSA-N

CAS Common Chemistry

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=41340-25-4

1 reference

language of work or name

Etodolac(English)

17 November 2016

2 references

language of work or name

etodolac(English)

17 November 2016

matched by identifier from

NNYBQONXHNTVIJ-UHFFFAOYSA-N

mapping relation type

3 references

language of work or name

ETODOLAC(English)

17 November 2016

ChEBI release 2019-10-02

matched by identifier from

International Chemical Identifier

InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)

1 reference

language of work or name

ETODOLAC(English)

17 November 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

NNYBQONXHNTVIJ-UHFFFAOYSA-N

UniChem compound ID

1 reference

MassBank accession ID

MSBNK-Eawag-EQ330801

0 references

MSBNK-Eawag-EQ330802

0 references

MSBNK-Eawag-EQ330803

0 references

MSBNK-Eawag-EQ330804

0 references

MSBNK-Eawag-EQ330805

0 references

MSBNK-Eawag-EQ330806

0 references

MSBNK-Eawag-EQ330851

0 references

MSBNK-Eawag-EQ330852

0 references

MSBNK-Eawag-EQ330853

0 references

MSBNK-Eawag-EQ330854

0 references

MSBNK-Eawag-EQ330855

0 references

MSBNK-Eawag-EQ330856

0 references

MSBNK-Keio_Univ-KO000739

0 references

MSBNK-Keio_Univ-KO000740

0 references

MSBNK-Keio_Univ-KO000741

0 references

MSBNK-Keio_Univ-KO000742

0 references

MSBNK-Keio_Univ-KO000743

0 references

MSBNK-Keio_Univ-KO008956

0 references

MSBNK-Keio_Univ-KO008957

0 references

MSBNK-Univ_Connecticut-CO000186

0 references

MSBNK-Univ_Connecticut-CO000187

0 references

MSBNK-Univ_Connecticut-CO000188

0 references

MSBNK-Univ_Connecticut-CO000189

0 references

MSBNK-Univ_Connecticut-CO000190

0 references

MSBNK-Keio_Univ-KO002864

0 references

MSBNK-Keio_Univ-KO002865

0 references

MSBNK-Keio_Univ-KO002866

0 references

MSBNK-Keio_Univ-KO002867

0 references

MSBNK-Keio_Univ-KO002868

0 references

splash10-00di-0920000000-22f891e69de842afb76f

0 references

splash10-00di-0910000000-3903a65f3f64f26aa9b7

0 references

splash10-006x-0900000000-5bb09419198c9ca084c0

0 references

splash10-0006-0900000000-61c0ea8a828fd0570b07

0 references

splash10-0006-0900000000-4bec68aee4ff03d6d386

0 references

splash10-000l-0090000000-cb5392bab35da402835e

0 references

splash10-0006-0090000000-66382e8a032519cc0610

0 references

splash10-03di-0090000000-1ab9e4ff7d60e90eca2c

0 references

splash10-03di-0290000000-308131d28773ab2c9701

0 references

splash10-03dj-0890000000-ba74bd4789a5df9d1095

0 references

splash10-01pk-0920000000-3003d9d94ce99518b55e

0 references

splash10-000i-0090000000-1644ab62d0cb24cc769e

0 references

splash10-000f-0090000000-0d0a55600dd433d684b1

0 references

splash10-01ox-0090000000-17b2c48a871d73f3071a

0 references

splash10-03di-0290000000-fe771b5ef7a99c3f79dd

0 references

splash10-03dj-0980000000-50aec638935d673b713e

0 references

splash10-00dr-0890000000-e286df97fed2602fd759

0 references

splash10-00di-0920000000-0323497d51f9000f512d

0 references

splash10-00di-0910000000-4c9034687504f43ca35d

0 references

splash10-006x-1900000000-c7af982a125d43d0a322

0 references

splash10-0006-1900000000-b6f0e91141ccbee49a24

0 references

splash10-00di-0930000000-16f06e354549b4eacb4c

0 references

splash10-00di-0900000000-8a146df68be1b53ea0d5

0 references

splash10-00dr-0970000000-8693e29717fb7601dfab

0 references

splash10-00di-0940000000-d9875ccdb5dd4639af09

0 references

splash10-00dl-0910000000-c7918fc03d252733ba5b

0 references

splash10-0006-0900000000-a45c507a9469f25641f1

0 references

splash10-0006-0900000000-c71c8b6e48beac782768

0 references

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

NNYBQONXHNTVIJ-UHFFFAOYSA-N

DSSTOX compound identifier

0 references

0 references

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid(English)

CAS no.: 41340-25-4(English)

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid(English)

CAS no.: 41340-25-4(English)

1 reference

language of work or name

Etodolac(English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

etodolac(English)

17 November 2016

MeSH descriptor ID

subject named as

Etodolac

0 references

D03.066.288.200

0 references

D03.633.100.473.404.200

0 references

1 reference

Global Substance Registration System

language of work or name

etodolac(English)

17 November 2016

1 reference

matched by identifier from

NNYBQONXHNTVIJ-UHFFFAOYSA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

NNYBQONXHNTVIJ-UHFFFAOYSA-N

2 references

Global Substance Registration System

language of work or name

etodolac(English)

17 November 2016

matched by identifier from

NNYBQONXHNTVIJ-UHFFFAOYSA-N

MedlinePlus drug identifier

0 references

1 reference

Global Substance Registration System

language of work or name

etodolac(English)

17 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

etodolac(English)

3 October 2016

IEDB Epitope ID

1 reference

Immune Epitope Database and Analysis Resource

IEDB Epitope ID

1 March 2022

1 reference

California Proposition 65 list of chemicals

6 January 2020

https://oehha.ca.gov/chemicals/etodolac

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Global Substance Registration System

language of work or name

etodolac(English)

17 November 2016

WikiProjectMed ID

0 references

WordNet 3.1 Synset ID

03305852-n

1 reference

Sitelinks

Wikipedia(21 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswikiCategory:Etodolac

Retrieved from "https://www.wikidata.org/w/index.php?title=Q2465218&oldid=2322865493"

[8]ページ先頭

©2009-2025 Movatter.jp